Seattle Cancer Care Alliance offers comprehensive consultations and treatments for aplastic anemia and other blood disorders.
SCCA was formed, in part, to bring promising new treatments to patients faster. This means that people who have been diagnosed with aplastic anemia will find more treatment options at SCCA than might be found elsewhere, including one of many clinical studies being conducted at SCCA and its parent organizations, Fred Hutch and UW Medicine.
If your condition requires a bone marrow transplant, you should know that the Fred Hutch Bone Marrow Transplant Program at SCCA is a leader in transplants. For example, we are pioneering reduced-intensity transplants, are developing transplant options for people who have not found a matched donor, and developed a comorbidity index that predicts which people are the best candidates for transplant. These advances are making transplant an option for people who might not otherwise be considered for the procedure.
In addition, we are one of 15 centers whose transplant patients achieved higher-than-expected survival rates, according to a multi-year study by the Center for International Blood and Marrow Transplant Research. The study compared patients at more than 165 bone marrow transplant centers in the United States. We’ve performed more bone marrow transplants than any other institution in the world.